Literature DB >> 1419842

Fluid, blood, and blood product management in the craniofacial patient.

E Wilkinson1, J Rieff, H L Rekate, S Beals.   

Abstract

This report is a retrospective review of the perioperative management of 56 children who underwent craniofacial surgical procedures. The use of a combination of 5% dextrose in normal saline or 5% dextrose in Ringer's lactate and normal saline resulted in postoperative sodium values in a normal range. In patients receiving a combination of 5% dextrose and electrolyte No. 48 and normal saline, the mean postoperative sodium level was 130 mEq/l with 9 of 18 patients below 130 mEq/l. Two patients in the series suffered clinical seizures on postoperative day 1 as a result of serum sodium levels of 122 and 121 mEq/l, respectively. We recommend that only solutions with a sodium content between 77 and 154 mEq/l be used routinely in the perioperative management of craniofacial patients.

Entities:  

Mesh:

Year:  1992        PMID: 1419842     DOI: 10.1159/000120641

Source DB:  PubMed          Journal:  Pediatr Neurosurg        ISSN: 1016-2291            Impact factor:   1.162


  4 in total

Review 1.  Hypotonic versus isotonic saline in hospitalised children: a systematic review.

Authors:  K Choong; M E Kho; K Menon; D Bohn
Journal:  Arch Dis Child       Date:  2006-06-05       Impact factor: 3.791

Review 2.  Synostectomy versus complex cranioplasty for the treatment of sagittal synostosis.

Authors:  F A Boop; K Shewmake; W M Chadduck
Journal:  Childs Nerv Syst       Date:  1996-07       Impact factor: 1.475

3.  Isotonic versus Hypotonic Intravenous Maintenance Fluids in Children: A Randomized Controlled Trial.

Authors:  Narendra K Bagri; Vidya K Saurabh; Sriparna Basu; Ashok Kumar
Journal:  Indian J Pediatr       Date:  2019-07-06       Impact factor: 1.967

4.  Intravenous fluid regimen and hyponatraemia among children: a randomized controlled trial.

Authors:  Lakshminarayanan Kannan; Rakesh Lodha; Subbiah Vivekanandhan; Arvind Bagga; Sushil K Kabra; Madhulika Kabra
Journal:  Pediatr Nephrol       Date:  2010-07-29       Impact factor: 3.714

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.